NCT04395911View on ClinicalTrials.gov

Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections

NACompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

July 5, 2021

Study Completion Date

July 21, 2021

Conditions

AKIARDSCOVID

Interventions

DEVICE

SCD

cytopheretic device

Trial Locations (3)

40506

University of Kentucky, Lexington

48109

University of Michigan, Ann Arbor

48202

Henry Ford Health System, Detroit

Sponsors

Lead Sponsor

SeaStar Medical

All Listed Sponsors

lead

SeaStar Medical

INDUSTRY

NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections | Biotech Hunter | Biotech Hunter